Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Distinguishing de novo second cancer formation from tumor recurrence: mutational fingerprinting by microdissection genotyping.

The Journal of molecular diagnostics : JMD - 1 Nov 2001

Rolston R, Sasatomi E, Hunt J, Swalsky P A, Finkelstein S D

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenocarcinoma
Share to Colonic Neoplasms
Share to Dissection
Share to DNA Fingerprinting

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Neoplasm Invasiveness

Share to Neoplasm Metastasis

Share to Neoplasm Recurrence, Local

Share to Neoplasms, Second Primary

Source

Open in PubMed Open full text

Identifiers

PMID: 11687595
DOI: 10.1016/S1525-1578(10)60663-0
PMCID: PMC1906959

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 9 closest

Distinguishing de novo second cancer formation from tumor recurrence: mutational fingerprinting by microdissection genotyping.PMID 11687595Read ↗

Emerging molecular technologies for identifying the risk of second cancers.Semantic proximity Read ↗

Microdissection-based genetic discovery and analysis applied to cancer progression.Semantic proximity Read ↗

Recurrent somatic mutations reveal new insights into consequences of mutagenic processes in cancer.Semantic proximity Read ↗

Identifying Locally Recurrent Versus Second Primary Breast Cancer: Genomic Versus Clinical Criteria from Carolina Breast Cancer Study Phase III.Semantic proximity Read ↗

Local recurrence versus new primary: Clinical analysis of 82 breast relapses and potential applications for genetic fingerprintingSemantic proximity Read ↗

Analysis of matched primary and recurrent BRCA1/2 mutation-associated tumors identifies recurrence-specific drivers.Semantic proximity Read ↗

Quantitative DNA fingerprinting may distinguish new primary breast cancer from disease recurrence.Semantic proximity Read ↗

Investigating a case of possible field cancerization in oral squamous cell carcinoma by the use of next-generation sequencing.Semantic proximity Read ↗

Comprehensive Genomic Profiling of Renal Cell Carcinoma at Initial Diagnosis and Putative Local Recurrence.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.